Distearoyl Anchor‐Painted Erythrocytes with Prolonged Ligand Retention and Circulation Properties In Vivo

Abstract

Red blood cells (RBCs) attract significant interest as carriers of biomolecules, drugs and nanoparticles. In this regard, versatile technologies to attach molecules and ligands to the RBC surface are of great importance. Reported here is a fast and efficient surface painting strategy to attach ligands to the surface of RBCs, and the factors that control the stability and circulation properties of the modified RBCs in vivo. Distearoyl phosphatidylethanolamine anchor-conjugated immunoglobulin (IgG) efficiently incorporates in the RBC membrane following 15–30 min incubation. The optimized RBCs show prolonged circulation in vivo (70% of the injected dose after 48h) and efficient retention of IgG in the membrane with terminal half-life of 73 hours. The IgG construct is gradually lost from the RBCs mainly due to the transfer to plasma components, liver endothelial cells and Kupffer cells. The ligand retention efficiency is partially dictated by ligand type, anchor type, and ligand concentration in the membrane, while RBC half-life is determined by initial concentration of the ligand in the membrane and presence of PEG linker between the ligand and the anchor. This work provides important guidance for non-covalent surface painting of RBCs as well as other types of blood borne cells for in vivo therapeutic and targeting applications.

Exploiting shape, cellular-hitchhiking and antibodies to target nanoparticles to lung endothelium: Synergy between physical, chemical and biological approaches

“…This explains revival in studies coupling drugs to RBCs [48][49][50][51]. However, the concept of RBC-hitchhiking nanocarriers capitalizes both on the pharmacokinetic advantages provided by RBC carriage and on previously unrecognized targeting mechanisms enabled by transfer of nanoparticles from RBC to the vascular cells [36][37][38].…”

Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems

“…[19–21]. More recently, RBCs painted with affinity ligands have been tested for targeting to circulating leukocytes [22,23]. …”

Erythrocytes as Carriers for Drug Delivery in Blood Transfusion and Beyond

“…Methods to couple therapeutics to the RBC surface have also been explored, including covalent conjugation via amino acids[52, 53], thiol groups[54, 55], sugars[56] and lipids[19, 57]. Examples of RBC surface loading include coupling of antigens and cytokines to stimulate the immune response[58] and antibodies that target RBC-loaded cargoes to their therapeutic sites[55, 59, 60].…”